Skip to content
  • Instagram
logo The Onco Doc

Oncology, Reinvented for Tomorrow

Get Newsletter
  • Home
  • Blogs
  • Authors
Home » Continuing Medical Education (CME) » Page 4
How Can You Future-Proof Your Oncology Marketing? 3 Messaging Shifts Pharma Brand Managers Must Make Now
Posted inPharma Marketing

How Can You Future-Proof Your Oncology Marketing? 3 Messaging Shifts Pharma Brand Managers Must Make Now

Posted by OncoDoc August 12, 2025
Abstract The pharmaceutical marketing landscape is in a constant state of flux, driven by both…
Read More
DTC Ad Ban: A Ticking Time Bomb? What U.S. Pharma Marketers Must Do Now
Posted inPharma Marketing

DTC Ad Ban: A Ticking Time Bomb? What U.S. Pharma Marketers Must Do Now

Posted by OncoDoc August 11, 2025
Abstract The landscape of pharmaceutical marketing in the United States is at a critical juncture.…
Read More
Beyond the Checkbox: How Compliance is Forcing a Digital Revolution in Oncology Marketing
Posted inPharma Marketing

Beyond the Checkbox: How Compliance is Forcing a Digital Revolution in Oncology Marketing

Posted by OncoDoc August 9, 2025
Abstract The digital frontier of medical oncology marketing, once a landscape of unbridled innovation, is…
Read More
Beyond the Hype: Which Technologies Will Truly Define Oncology Marketing in 2025?
Posted inPharma Marketing

Beyond the Hype: Which Technologies Will Truly Define Oncology Marketing in 2025?

Posted by OncoDoc August 8, 2025
Abstract The rapid evolution of technology, combined with the increasing complexity of oncology care, is…
Read More
Post-Election Pharma
Posted inPharma Marketing

Post-Election Pharma: What U.S. Policy Changes Mean for Global Oncology Marketers

Posted by OncoDoc August 7, 2025
Abstract The outcome of U.S. elections often ushers in significant policy changes with far-reaching consequences…
Read More
Pharma 5.0’s Global Shift: Powered by India
Posted inPharma Marketing

Pharma 5.0’s Global Shift: Powered by India

Posted by OncoDoc August 6, 2025
Introduction: The Dawn of a Global-First India in Pharma Marketing In 2025, a quiet revolution…
Read More
Is a Recession Reshaping Your Oncology Marketing Strategy? Navigating Economic Headwinds in an Evolving Healthcare Market
Posted inPharma Marketing

Is a Recession Reshaping Your Oncology Marketing Strategy? Navigating Economic Headwinds in an Evolving Healthcare Market

Posted by OncoDoc August 6, 2025
Abstract The medical oncology market, traditionally viewed as recession-resilient due to the non-discretionary nature of…
Read More
How Policy Shifts in the Trump Era Redefined Medical Oncology Marketing?
Posted inPharma Marketing

How Policy Shifts in the Trump Era Redefined Medical Oncology Marketing?

Posted by OncoDoc August 5, 2025
Abstract The medical oncology landscape, a field defined by its rapid innovation and stringent regulatory…
Read More
The integration of artificial intelligence (AI) into oncology marketing has been hailed as a revolutionary step forward
Posted inPharma Marketing

Is AI limiting the scope of Oncology Marketing? The Hidden Dangers for Pharma managers.

Posted by OncoDoc August 4, 2025
Abstract The integration of artificial intelligence (AI) into oncology marketing has been hailed as a…
Read More
What are the Best Analytics Tools for Oncology Pharma Marketers?
Posted inPharma Marketing

What are the Best Analytics Tools for Oncology Pharma Marketers?

Posted by OncoDoc August 2, 2025
Abstract The oncology pharmaceutical market, characterized by its scientific complexity and stringent regulatory oversight, demands…
Read More

Posts pagination

Previous page 1 2 3 4 5 6 Next page

Stay informed. Stay ahead.
Get the latest oncology
insights and pharma
marketing trends delivered
straight to your inbox.
Subscribe to our Newsletter!

India: Infedis Infotech LLP.
1st Floor, Office No 108, S No 557 A 1 CTS No
97, Suyog Center, Gultekdi, Pune, Maharashtra
For Queries/Grievances, Contact : V. Gadia
+91-9665017922
info@hidoc.co
LLP Identification Number : AAH-8647

Infedis Health Private Limited.
Suyog Center, Office No. 108, 1st Floor, Gultekdi, Pune, Maharashtra, India - 411037
CIN of the Company : U74999PN2018PTC175141

US : Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
+1 (415) 463-3094

CSR Policy

Copyright 2025 â€” The Onco Doc. All rights reserved.
Terms & Conditions - LLP |  Inc. |  Privacy Policy - LLP |  Inc. |  Account Deactivation
Scroll to Top